Mitsubishi UFJ Trust & Banking’s Harmony Biosciences HRMY Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$494K	Buy	+13,570	New	+$428K	﹤0.01%	1057

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's HRMY Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 13,570 shares worth $494K. The stake represents ﹤0.01% of the portfolio and ranks #1057 among its holdings.

326 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 13,570 shares of Harmony Biosciences worth $494K as of Q2 2026.
Harmony Biosciences was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
Harmony Biosciences made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1057 holding.
326 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.